Anti-oxidative effect of the tyrosine kinase inhibitor nintedanib: a potential therapy for chronic lung allograft dysfunction?

Elke Boxhammer; Karla Lehle; Christof Schmid; Marietta von Suesskind-Schwendi

doi:10.1080/01902148.2020.1738594

Anti-oxidative effect of the tyrosine kinase inhibitor nintedanib: a potential therapy for chronic lung allograft dysfunction?

Elke Boxhammer (First author), Karla Lehle, Christof Schmid, Marietta von Suesskind-Schwendi

Research output: Contribution to journal › Original Article › peer-review

10 Citations (Web of Science)

Original language	English
Pages (from-to)	128-145
Journal	EXPERIMENTAL LUNG RESEARCH
Volume	46
Issue number	5
DOIs	https://doi.org/10.1080/01902148.2020.1738594
Publication status	Published - 2020

Keywords

BRONCHIOLITIS OBLITERANS SYNDROME
OXIDATIVE STRESS
CYCLOSPORINE-A
TISSUE TRANSGLUTAMINASE
COLORIMETRIC ASSAY
GROWTH-FACTOR
INFLAMMATION
FIBROBLASTS
PROTECTS
FIBROSIS

Access to Document

10.1080/01902148.2020.1738594

Cite this

@article{297ddb46354b44f7a1d6a395a764f323,

title = "Anti-oxidative effect of the tyrosine kinase inhibitor nintedanib: a potential therapy for chronic lung allograft dysfunction?",

keywords = "BRONCHIOLITIS OBLITERANS SYNDROME, OXIDATIVE STRESS, CYCLOSPORINE-A, TISSUE TRANSGLUTAMINASE, COLORIMETRIC ASSAY, GROWTH-FACTOR, INFLAMMATION, FIBROBLASTS, PROTECTS, FIBROSIS",

author = "Elke Boxhammer and Karla Lehle and Christof Schmid and {von Suesskind-Schwendi}, Marietta",

year = "2020",

doi = "10.1080/01902148.2020.1738594",

language = "English",

volume = "46",

pages = "128--145",

journal = "EXPERIMENTAL LUNG RESEARCH",